These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25942664)
1. Safe and efficacious use of intralesional steroids for the treatment of focally resistant mycosis fungoides. Liu DY; Shaath T; Rajpara AN; Hanson C; Fraga G; Fischer R; Aires DJ J Drugs Dermatol; 2015 May; 14(5):466-71. PubMed ID: 25942664 [TBL] [Abstract][Full Text] [Related]
2. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides. Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334 [TBL] [Abstract][Full Text] [Related]
3. Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides. Hu JK; Carlson K; Girardi M Yale J Biol Med; 2020 Mar; 93(1):41-44. PubMed ID: 32226334 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
5. Safe and efficacious use of a topical retinoid under occlusion for the treatment of mycosis fungoides. Aires D; Shaath T; Fraga G; Rajpara A; Fischer R; Liu D J Drugs Dermatol; 2014 Dec; 13(12):1479-80. PubMed ID: 25607792 [No Abstract] [Full Text] [Related]
6. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine. Heisig M; Maj J; Szepietowski JC; Reich A Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921 [TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
8. CD8+ mycosis fungoides clinically masquerading as alopecia areata. Amin SM; Tan T; Guitart J; Colavincenzo M; Gerami P; Yazdan P J Cutan Pathol; 2016 Dec; 43(12):1179-1182. PubMed ID: 27546732 [TBL] [Abstract][Full Text] [Related]
10. Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational study. Geller S; Myskowski PL Cutis; 2020 May; 105(5):E27-E32. PubMed ID: 32603400 [TBL] [Abstract][Full Text] [Related]
11. Response to topical corticosteroid monotherapy in mycosis fungoides. Kartan S; Shalabi D; O'Donnell M; Alpdogan SO; Sahu J; Shi W; Porcu P; Cha J; Nikbakht N J Am Acad Dermatol; 2021 Mar; 84(3):615-623. PubMed ID: 32428610 [TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients. Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240 [TBL] [Abstract][Full Text] [Related]
13. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. Lewis DJ; Byekova YA; Emge DA; Duvic M J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518 [TBL] [Abstract][Full Text] [Related]
14. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511 [TBL] [Abstract][Full Text] [Related]
15. Role of radiation therapy in mycosis fungoides refractory to systemic therapy. de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904 [TBL] [Abstract][Full Text] [Related]
16. Skin directed therapy for mycosis fungoides: a review. Berthelot C; Rivera A; Duvic M J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158 [TBL] [Abstract][Full Text] [Related]
17. Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patients. de Masson A; Battistella M; Vignon-Pennamen MD; Cavelier-Balloy B; Mouly F; Rybojad M; Bouaziz JD; Petit A; Saussine A; Ronceray S; Le Gall F; Ram-Wolff C; Assouly P; Dereure O; Joly P; Dallot A; Dupuy A; Lebbé C; Moulonguet I; Rivet J; Janin A; Bagot M J Am Acad Dermatol; 2014 Nov; 71(5):926-34. PubMed ID: 25044343 [TBL] [Abstract][Full Text] [Related]
18. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature. Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612 [TBL] [Abstract][Full Text] [Related]
20. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study. de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]